SeeThruEquity, LLC, a leading force in the equity research business, today announced the launch of its free equity research platform and social media interactive website at www.seethruequity.com. SeeThruEquity strives to change the dynamic in the equity research space. SeeThruEquity is providing research on U.S. companies with market capitalizations below $1 billion, specifically on smallcap companies that have little or no coverage from the Wall Street analyst community. And, the company is offering unbiased institutional equity research reports free of charge to all. Its goal is to level the playing field for all investors. Amit Tandon, a co-founder and Chief Executive Officer of SeeThruEquity commented, “We believe that smallcap companies represent some of the most exciting investment opportunities in the U.S. capital markets, yet the vast majority of public companies do not have any research coverage whatsoever.” “To this end, SeeThruEquity believes that providing free, totally unbiased, and truly independent research will heighten the level of visibility which currently only the largest of companies have. This mission, together with an ability to provide access to institutional equity research to the entire financial community, provides SeeThruEquity the foundation to deliver valuable insights and actionable investment ideas to the entire investment community,” added Mr. Tandon. SeeThruEquity is initiating coverage of the following companies with its website launch:
|-Harvard Bioscience||(NASDAQ: HBIO)|
|-Intersections, Inc.||(NASDAQ: INTX)|
|-Telular Corp.||(NASDAQ: WRLS)|
About SeeThruEquitySeeThruEquity, LLC is a research analytics firm based in New York City focused on providing institutional equity research of small cap companies based in the U.S. SeeThruEquity’s revolutionary new social media, web-based platform offering institutional and truly independent equity research reports of smallcap public companies is available free to users on its website at seethruequity.com.